Axsome Therapeutics, Inc. · Biotechnology

AXSMAxsome Therapeutics, Inc.

Reports 2026-11-02 Pre-market · MonReaction day 11-02upcoming

Before the print · expectations4 days to the print

Street consensus

−$0.53EPS

$256MRevenue

No past prints on file yet.

What the record doesn't tell you

Which way does AXSM go on 11‑02?

Model lean for 11-02, and the evidence behind it
Move band, P10 – P90
Last 8 prints, quarter by quarter
Peers that already reported, and how they traded

Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-02 · Pre-market

Revenue—

est. $256M

EPS—

est. −$0.53

Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Axsome Therapeutics earnings preview: what the record says

Axsome Therapeutics (AXSM) is scheduled to report earnings on Nov 2, 2026, before the open. The consensus estimate calls for EPS of −$0.53 on revenue of $256M.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

AXSM earnings: key questions

When is AXSM's next earnings date?

Axsome Therapeutics is scheduled to report on Nov 2, 2026, before the open.

What are AXSM's earnings expectations?

Analysts expect EPS of −$0.53 on revenue of $256M for the quarter.